Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review

被引:0
|
作者
Laura Martelli
Pablo Olivera
Xavier Roblin
Alain Attar
Laurent Peyrin-Biroulet
机构
[1] Université de Lorraine,Department of Hepato
[2] University Hospital of Saint Etienne,Gastroenterology, University Hospital of Nancy
[3] Beaujon Hospital,Department of Gastroenterology
[4] université de Lorraine,Department of Gastroenterology, IBD, Nutritional Support
来源
Journal of Gastroenterology | 2017年 / 52卷
关键词
Cost savings; Trough concentrations; Infliximab; Inflammatory bowel disease; Rheumatoid arthritis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:19 / 25
页数:6
相关论文
共 50 条
  • [1] Cost-effectiveness of drug monitoring of anti-TNF therapy in inflammatory bowel disease and rheumatoid arthritis: a systematic review
    Martelli, Laura
    Olivera, Pablo
    Roblin, Xavier
    Attar, Alain
    Peyrin-Biroulet, Laurent
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (01) : 19 - 25
  • [2] Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review
    Marquez-Megias, Silvia
    Nalda-Molina, Ricardo
    Sanz-Valero, Javier
    Mas-Serrano, Patricio
    Diaz-Gonzalez, Marcos
    Candela-Boix, Maria Remedios
    Ramon-Lopez, Amelia
    PHARMACEUTICS, 2022, 14 (05)
  • [3] A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy
    Yao, Jiaqi
    Jiang, Xinchan
    You, Joyce H. S.
    INFLAMMATORY BOWEL DISEASES, 2021, 27 (02) : 275 - 282
  • [4] Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease
    Frank I. Scott
    Gary R. Lichtenstein
    Current Treatment Options in Gastroenterology, 2014, 12 (1) : 59 - 75
  • [5] Therapeutic drug monitoring of anti-TNF therapy in children with inflammatory bowel disease
    van Hoeve, Karen
    Hoffman, Ilse
    Vermeire, Severine
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (02) : 185 - 196
  • [6] Paradoxical Inflammatory Bowel Disease Following Anti-TNF Alpha Therapy for Rheumatoid Arthritis
    Das, Nikita
    Dhamija, Ravi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S35 - S35
  • [7] ANTI-TNF THERAPY INDUCED ARTHRITIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Reilly, Elizabeth
    Edwards, Cathryn
    Mackay, Kirsten
    RHEUMATOLOGY, 2015, 54 : 94 - 94
  • [8] Adherence to Anti-TNF Therapy in Inflammatory Bowel Diseases: A Systematic Review
    Lopez, Anthony
    Billioud, Vincent
    Peyrin-Biroulet, Carina
    Peyrin-Biroulet, Laurent
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (07) : 1528 - 1533
  • [9] Cost-effectiveness of therapeutic drug monitoring in inflammatory bowel disease
    McNeill, Richard P.
    Barclay, Murray L.
    CURRENT OPINION IN PHARMACOLOGY, 2020, 55 : 41 - 46
  • [10] Efficacy of therapeutic drug monitoring of anti-TNF therapy in the control of patients with inflammatory bowel disease
    Bernardo, S.
    Fernandes, S.
    Goncalves, A. R.
    Baldaia, C.
    Valente, A.
    Moura Santos, P.
    Correia, L.
    Velosa, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S308 - S309